Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Naokuni Yamawaki"'
Autor:
Hirokazu Onodera, Yumi Abe, Makoto Yoshida, Naokuni Yamawaki, Yasuhiko Yamashita, Hidenori Matsuo, Katsuhiro Ichinose, Izumi Otsuru, Noritoshi Shibuya
Publikováno v:
Therapeutic Apheresis. 4:161-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d734b089b7eb24d10d56b7a4ebebe423
https://doi.org/10.1046/j.1526-0968.2000.004002161.x
https://doi.org/10.1046/j.1526-0968.2000.004002161.x
Publikováno v:
Therapeutic Apheresis. 2:185-192
Immusorba was reported by Yamazaki et al. to be the world's first practical immunoadsorbent in 1982. Since then, this immunoadsorbent has accumulated an abundance of clinical achievements. Immusorba has such unique functions that it is used in treati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f6a0f5956089f157f70c1f43c1f112
https://doi.org/10.1111/j.1744-9987.1998.tb00102.x
https://doi.org/10.1111/j.1744-9987.1998.tb00102.x
Autor:
Yu-Ichi Tamura, Shu-ichi Ikeda, Takahiko Tokuda, Makoto Yoshida, Naoko Hanaoka, Fuyuki Kametani, Terutaka Kondo, Naokuni Yamawaki, Yo-ichi Takei, Yukihiro Yamada
Publikováno v:
Amyloid. 5:111-116
A transthyretin (TTR)-adsorption column has been developed for the removal of variant TTR from the plasma of patients with familial amyloid polyneuropathy (FAP). The adsorbent is an ion-exchange resin made of porous beads of polyvinyl alcohol gel cov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d252e852b4d2707fb5bd75ab960b89c0
https://doi.org/10.3109/13506129808995288
https://doi.org/10.3109/13506129808995288
Autor:
Satoshi Fujishit, Hirokazu Onodera, Naokuni Yamawaki, Noritoshi Shibuya, Junsuke Suematsu, Izumi Ohtsuru, Hidenori Matsuo, Katsuhiro Ichinose, Makoto Yoshida
Publikováno v:
Therapeutic Apheresis. 1:165-168
Experimental allergic encephalomyelitis (EAE) is a major animal model of human multiple sclerosis (MS). The pathogenesis of both MS and EAE directly involves CD4+ helper T cells. To remove CD4+ T cells selectively from the circulation, we designed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2aa905160c8c8d818c7ace4c86b396
https://doi.org/10.1111/j.1744-9987.1997.tb00034.x
https://doi.org/10.1111/j.1744-9987.1997.tb00034.x
Autor:
Tsuneo A. Takahashi, Seiji Chiba, Mari Hosoda, Yuko Mogi, Takao Nishimura, Hiroko Ohchi, Naokuni Yamawaki, Momoyo Nasu, Shin-ichiroh Oka, Sadayoshi Sekiguchi
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 38:401-407
The new high-performance R-S350 leukocyte removal filter was developed to deplete leukocytes from red cell concentrate and whole blood with high efficiency, that is, a higher than 4-log reduction. When 1 unit of red cell concentrate stored for 1 to 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::414640c9537e7289e3377248c64fdf3c
https://doi.org/10.3925/jjtc1958.38.401
https://doi.org/10.3925/jjtc1958.38.401
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9f6aa09ff09f753bcc6efb29750bd57
https://pubmed.ncbi.nlm.nih.gov/15197943
https://pubmed.ncbi.nlm.nih.gov/15197943
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 7(1)
Cellsorba is a leukocyte removal filter developed by Asahi Medical Co., which adsorbs white blood cells through the perfusion of peripheral blood by means of simple extracorporeal circulation. Leukocytapheresis (LCAP) therapy using the Cellsorba colu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b5a424e23bd20cc1ef7d7bb51130e13
https://pubmed.ncbi.nlm.nih.gov/12921114
https://pubmed.ncbi.nlm.nih.gov/12921114
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 7(1)
Immusorba TR (IM-TR) and PH (IM-PH) were developed as adsorbents with non-biological materials as affinity ligands to remove pathogenic autoantibodies. The adsorbents of IM-TR and IM-PH are polyvinyl alcohol gel immobilized with tryptophan and phenyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01363ae8e98ad4c527d58f41ce86035
https://pubmed.ncbi.nlm.nih.gov/12921121
https://pubmed.ncbi.nlm.nih.gov/12921121
Autor:
Yoshida Hajime, Jun-ichi Shirokaze, Naokuni Yamawaki, Noriko Hirata, Yasumasa Shizume, Junsuke Suemitsu
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 7(1)
In recent years, polyethylene and polysulfone membranes have been used for plasma separation in Japan. The polyethylene membrane, manufactured by melt spinning method, has a sponge-like symmetric structure. The plasma separator Plasmaflo OP (Asahi Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d46de4e9815e511685c595c3bc8ac9
https://pubmed.ncbi.nlm.nih.gov/12921117
https://pubmed.ncbi.nlm.nih.gov/12921117
Autor:
Naokuni Yamawaki, Noritoshi Shibuya, Katsuhiro Ichinose, Makoto Yoshida, Izumi Otsuru, Hidenori Matsuo, Hirokazu Onodera, Yasuhiko Yamashita, Yumi Abe
Publikováno v:
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis. 2(1)
Guest Editor's Introduction: As the leukocyte removal has been recognized as an effective means of therapy, efforts were focused on the device development for more specific removal of cellular components, which are related to the cause of the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6171c2e53dde948733dcd3d11f1a6f5e
https://pubmed.ncbi.nlm.nih.gov/10227787
https://pubmed.ncbi.nlm.nih.gov/10227787